Last reviewed · How we verify
NCT05183633
A Pilot Study to Assess the Association Between Human Bioimpedance Measurements and Clinical Urodynamic Procedures
trial in Patients Susceptible to Falls in 40 participants. Terminated before completion.
3 February 2025
Quick facts
| Lead sponsor | Curbell Medical Products, Inc. |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 40 |
| Start date | 10 May 2022 |
| Primary completion | 3 February 2025 |
| Estimated completion | 3 February 2025 |
| Sites | 1 location across United States |
Conditions studied
- Patients Susceptible to Falls — all drugs for Patients Susceptible to Falls →
Sponsor
Curbell Medical Products, Inc.
Who can join
Eligibility, any sex, with Patients Susceptible to Falls. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A Pilot Study to Assess the Association between Human Bioimpedance Measurements and Clinical Urodynamic Procedures
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05183633
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05183633 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Curbell Medical Products, Inc.
- Last refreshed: 6 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05183633.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing